Concepedia

Miguel Quiliano

MQ

Statistics

Publications

21

Citations

751

H-Index

17

Active since

2008

Affiliations

Universidad Peruana Cayetano Heredia(Current)

Universidad de Navarra

Université Toulouse III - Paul Sabatier

Pharmacochimie et Biologie pour le Développement

Université Fédérale de Toulouse Midi-Pyrénées

Miguel Quiliano is an author at Universidad Peruana Cayetano Heredia specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2008–2022

21

Publications

21

Synthesis, Cytotoxicity, and Anti-<i>Trypanosoma cruzi</i> Activity of New Chalcones

José C. Aponte, Manuela Verástegui, Edith Málaga et al. · Journal of Medicinal Chemistry · 2008 · 120 citations

, , +15

New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities

Carlos Barea, Adriana Pabón, Denis Castillo et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 60 citations · Full text

, , +16

Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies

Leonardo Bonilla-Ramírez, Alexandra Ríos, Miguel Quiliano et al. · European Journal of Medicinal Chemistry · 2018 · 50 citations

, , +16

Trypanocidal properties, structure–activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives

Yannick Estevez, Miguel Quiliano, Asunción Burguete et al. · Experimental Parasitology · 2011 · 49 citations · Full text

, , +15

Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO

Gabriel Jiménez-Avalos, A. Paula Vargas-Ruiz, Nicolás E. Delgado-Pease et al. · Scientific Reports · 2021 · 46 citations · Full text

, , +16

1–5 of 21